Oregon will receive $ 11.1 million for drug prevention and treatment services as part of national settlement with eight opioid manufacturers.
Opioid manufacturers, including MyLan, Hikma, Amneal, Apotex, Indivior, Sun, Alvogen and Zydus, have agreed to pay a total of $ 770 million for Oregon and eight states.
This agreement will be added to the $ 700 million Oregon secured from July 2021. $ 66 million agreement In June Sackler family and Purdue Pharma.
45%of the funds will go to the Lord Opioid Settlement Fund And 55%will go to the prevention and recovery program of county and cities. Oregon’s consensus prevention, treatment and recovery committee There is a plan to distribute funds by 2038.
Attorney General Dan Rayfield said in a press release that opioid manufacturers should be responsible for the damage caused by their families.
“No one can repeat the clock, but this money will allow you to continue to build the future in this crisis by investing in drug treatment, prevention and recovery support throughout our state.”
Other states related to this agreement include California, Colorado, Illinoi, New York, North Carolina, Tennessee, Utah and Virginia.
-Mia Maldonado, Oregon Capital Chronicle
Oregon Capital Chronicle is part of NewsroomThe largest state -centered non -profit news organization in the United States.
You can get rewards by purchasing a product or registering it with your account through a link from our site. By using this site, you agree with us User contract I agree that your click, interaction and personal information can be collected, recorded and/or stored by our company and social media and other partners. Personal information protection policy.
